Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:2068-2074

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Böger, R. H.
Right arrow Articles by Frölich, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Böger, R. H.
Right arrow Articles by Frölich, J. C.

(Circulation. 1997;95:2068-2074.)
© 1997 American Heart Association, Inc.


Articles

Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease

Rainer H. Böger, MD; Stefanie M. Bode-Böger, MD; Wolfgang Thiele; Wolfgang Junker; Klaus Alexander, MD; Jürgen C. Frölich, MD

From the Institute of Clinical Pharmacology and Department of Angiology (K.A.), Medical School, Hannover, Germany.

Background We studied urinary nitrate and cGMP excretion rates, indices of systemic NO formation, and plasma concentrations of L-arginine and the endogenous NO synthase inhibitor asymmetrical dimethylarginine (ADMA) and its inactive stereoisomer, symmetrical dimethylarginine, in 77 patients with peripheral arterial occlusive disease (PAOD) in Fontaine stages IIb through IV and in 47 young and 37 elderly healthy control subjects.

Methods and Results Urinary nitrate excretion was 182.0±11.4 µmol/mmol creatinine and cGMP excretion was 186.2±13.0 nmol/mmol creatinine in young healthy control subjects. In elderly control subjects, both excretion rates were slightly lower (nitrate, 156.0±7.8 µmol/mmol creatinine; cGMP, 150.0±8.3 nmol/mmol creatinine; P=NS). In PAOD patients, there was a significant, progressive reduction of urinary nitrate (IIb, 138.4±11.9; III, 128.6±11.3; and IV, 91.9±8.0 µmol/mmol creatinine; P<.05) and cGMP (IIb, 139.9±25.2; III, 115.6±13.1; and IV, 76.9±7.9 nmol/mmol creatinine; P<.05) excretion rates related to the Fontaine stage of PAOD. These changes were independent of changes in renal excretory function. Plasma L-arginine concentrations were not significantly different between the groups, but ADMA concentrations were elevated in PAOD patients (young control subjects, 1.25±0.11; elderly control subjects, 1.01±0.05 µmol/L; IIb, 2.62±0.24; III, 3.06±0.48; and IV, 3.49±0.26 µmol/L; P<.05 for PAOD versus control subjects). There was a significant linear correlation between urinary nitrate and cGMP excretion rates and a significant negative linear correlation between plasma ADMA concentrations and urinary nitrate excretion.

Conclusions In PAOD patients, there is a progressive reduction in urinary nitrate and cGMP excretion rates, which may be caused in part by accumulation of ADMA, an endogenous inhibitor of NO synthase.


Key Words: hypercholesterolemia • atherosclerosis • endothelium-derived factors • risk factors




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Leong, D. Zylberstein, I. Graham, L. Lissner, D. Ward, J. Fogarty, C. Bengtsson, C. Bjorkelund, D. Thelle, and for The Swedish-Irish-Norwegian (SIN) Collaboratio
Asymmetric Dimethylarginine Independently Predicts Fatal and Nonfatal Myocardial Infarction and Stroke in Women: 24-Year Follow-Up of the Population Study of Women in Gothenburg
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 961 - 967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Game, J. Allard, G. Escourrou, P. Gourdy, I. Tack, P. Rischmann, J.-F. Arnal, and B. Malavaud
Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R851 - R857.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Lucke, N. Kanzelmeyer, K. Chobanyan, D. Tsikas, D. Franke, M. J. Kemper, J. H.H. Ehrich, and A. M. Das
Elevated asymmetric dimethylarginine (ADMA) and inverse correlation between circulating ADMA and glomerular filtration rate in children with sporadic focal segmental glomerulosclerosis (FSGS)
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 734 - 740.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Park, H. Itoh, K. Yamahara, M. Sone, K. Miyashita, N. Oyamada, N. Sawada, D. Taura, M. Inuzuka, T. Sonoyama, et al.
Therapeutic Potential of Atrial Natriuretic Peptide Administration on Peripheral Arterial Diseases
Endocrinology, February 1, 2008; 149(2): 483 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Matsumoto, S. Ueda, S.-i. Yamagishi, K. Matsuguma, R. Shibata, K. Fukami, H. Matsuoka, T. Imaizumi, and S. Okuda
Dimethylarginine Dimethylaminohydrolase Prevents Progression of Renal Dysfunction by Inhibiting Loss of Peritubular Capillaries and Tubulointerstitial Fibrosis in a Rat Model of Chronic Kidney Disease
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1525 - 1533.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Toth, A. Racz, P. M. Kaminski, M. S. Wolin, Z. Bagi, and A. Koller
Asymmetrical Dimethylarginine Inhibits Shear Stress-Induced Nitric Oxide Release and Dilation and Elicits Superoxide-Mediated Increase in Arteriolar Tone
Hypertension, March 1, 2007; 49(3): 563 - 568.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Mittermayer, K. Krzyzanowska, M. Exner, W. Mlekusch, J. Amighi, S. Sabeti, E. Minar, M. Muller, M. Wolzt, and M. Schillinger
Asymmetric Dimethylarginine Predicts Major Adverse Cardiovascular Events in Patients With Advanced Peripheral Artery Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2536 - 2540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. S. Billecke, L. A. Kitzmiller, J. J. Northrup, S. E. Whitesall, M. Kimoto, A. V. Hinz, and L. G. D'Alecy
Contribution of whole blood to the control of plasma asymmetrical dimethylarginine
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1788 - H1796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Fetalvero, M. Shyu, A. P. Nomikos, Y.-F. Chiu, R. J. Wagner, R. J. Powell, J. Hwa, and K. A. Martin
The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1337 - H1346.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
M. Sahin, C. Arslan, M. Naziroglu, S. E. Tunc, M. Demirci, R. Sutcu, and N. Yilmaz
Asymmetric Dimethylarginine and Nitric Oxide Levels as Signs of Endothelial Dysfunction in Behcet's Disease
Ann. Clin. Lab. Sci., January 1, 2006; 36(4): 449 - 454.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Reimann, J. Dierkes, A. Carlsohn, D. Talbot, M. Ferrari, J. Hallund, W. L. Hall, K. Vafeiadou, U. Huebner, F. Branca, et al.
Consumption of Soy Isoflavones Does Not Affect Plasma Total Homocysteine or Asymmetric Dimethylarginine Concentrations in Healthy Postmenopausal Women
J. Nutr., January 1, 2006; 136(1): 100 - 105.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. A. Carello, S. E. Whitesall, M. C. Lloyd, S. S. Billecke, and L. G. D'Alecy
Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H209 - H216.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
R. K Oka, A. Szuba, J. C Giacomini, and J. P Cooke
A pilot study of l-arginine supplementation on functional capacity in peripheral arterial disease
Vascular Medicine, November 1, 2005; 10(4): 265 - 274.
[Abstract] [PDF]


Home page
Circ. Res.Home page
R. Schnabel, S. Blankenberg, E. Lubos, K. J. Lackner, H. J. Rupprecht, C. Espinola-Klein, N. Jachmann, F. Post, D. Peetz, C. Bickel, et al.
Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease: Results from the AtheroGene Study
Circ. Res., September 2, 2005; 97(5): e53 - e59.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Perticone, A. Sciacqua, R. Maio, M. Perticone, R. Maas, R. H. Boger, G. Tripepi, G. Sesti, and C. Zoccali
Asymmetric Dimethylarginine, L-Arginine, and Endothelial Dysfunction in Essential Hypertension
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 518 - 523.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
I. Qureshi, H. Chen, A. T Brown, R. Fitzgerald, X. Zhang, J. Breckenridge, R. Kazi, A. J Crocker, M. C Stuhlingexsr, K. Lin, et al.
Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor
Vascular Medicine, August 1, 2005; 10(3): 215 - 223.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. E. Girgis, H. C. Champion, G. B. Diette, R. A. Johns, S. Permutt, and J. T. Sylvester
Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension: Response to Bosentan Therapy
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 352 - 357.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. T. Kielstein, S. M. Bode-Boger, G. Hesse, J. Martens-Lobenhoffer, A. Takacs, D. Fliser, and M. M. Hoeper
Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1414 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
J. P Cooke
ADMA: its role in vascular disease
Vascular Medicine, May 1, 2005; 10(2_suppl): S11 - S17.
[Abstract] [PDF]


Home page
Vasc MedHome page
R. H Boger
Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials
Vascular Medicine, May 1, 2005; 10(2_suppl): S19 - S25.
[Abstract] [PDF]


Home page
Vasc MedHome page
R. H Boger, E. Schwedhelm, R. Maas, S. Quispe-Bravo, and C. Skamira
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study
Vascular Medicine, May 1, 2005; 10(2_suppl): S97 - S102.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Ziegler, F. Mittermayer, C. Plank, E. Minar, M. Wolzt, and G.-H. Schernthaner
Homocyst(e)ine-Lowering Therapy Does Not Affect Plasma Asymmetrical Dimethylarginine Concentrations in Patients with Peripheral Artery Disease
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2175 - 2178.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Koga, Y. Akita, J. Nishioka, S. Yatsuga, N. Povalko, Y. Tanabe, S. Fujimoto, and T. Matsuishi
L-Arginine improves the symptoms of strokelike episodes in MELAS
Neurology, February 22, 2005; 64(4): 710 - 712.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Krzyzanowska, F. Mittermayer, H.-P. Kopp, M. Wolzt, and G. Schernthaner
Weight Loss Reduces Circulating Asymmetrical Dimethylarginine Concentrations in Morbidly Obese Women
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6277 - 6281.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Scalera, J. Borlak, B. Beckmann, J. Martens-Lobenhoffer, T. Thum, M. Tager, and S. M. Bode-Boger
Endogenous Nitric Oxide Synthesis Inhibitor Asymmetric Dimethyl L-Arginine Accelerates Endothelial Cell Senescence
Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1816 - 1822.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. H. Boger
Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the "L-Arginine Paradox" and Acts as a Novel Cardiovascular Risk Factor
J. Nutr., October 1, 2004; 134(10): 2842S - 2847S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. J. Nijveldt, M. P. C. Siroen, T. Teerlink, and P. A. M. van Leeuwen
Elimination of Asymmetric Dimethylarginine by the Kidney and the Liver: A Link to the Development of Multiple Organ Failure?
J. Nutr., October 1, 2004; 134(10): 2848S - 2852S.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Suda, M. Tsutsui, T. Morishita, H. Tasaki, S. Ueno, S. Nakata, T. Tsujimoto, Y. Toyohira, Y. Hayashida, Y. Sasaguri, et al.
Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase-Deficient Mice: Involvement of Renin-Angiotensin System and Oxidative Stress
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1682 - 1688.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y. Momohara, S. Sakamoto, S. Obayashi, T. Aso, M. Goto, and H. Azuma
Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat
Mol. Hum. Reprod., July 1, 2004; 10(7): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
K. Sydow, B. Hornig, N. Arakawa, S. M Bode-Boger, D. Tsikas, T. Munuzel, and R. H Boger
Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA
Vascular Medicine, May 1, 2004; 9(2): 93 - 101.
[Abstract] [PDF]


Home page
CirculationHome page
J. P. Cooke
Asymmetrical Dimethylarginine: The Uber Marker?
Circulation, April 20, 2004; 109(15): 1813 - 1818.
[Full Text] [PDF]


Home page
CirculationHome page
Y. Higashi, M. Kimura, K. Hara, K. Noma, D. Jitsuiki, K. Nakagawa, T. Oshima, K. Chayama, T. Sueda, C. Goto, et al.
Autologous Bone-Marrow Mononuclear Cell Implantation Improves Endothelium-Dependent Vasodilation in Patients With Limb Ischemia
Circulation, March 16, 2004; 109(10): 1215 - 1218.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. T. Kielstein, B. Impraim, S. Simmel, S. M. Bode-Boger, D. Tsikas, J. C. Frolich, M. M. Hoeper, H. Haller, and D. Fliser
Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans
Circulation, January 20, 2004; 109(2): 172 - 177.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. J. Nijveldt, T. Teerlink, C. van Guldener, H. A. Prins, A. A. van Lambalgen, C. D. A. Stehouwer, J. A. Rauwerda, and P. A. M. van Leeuwen
Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia
Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2542 - 2550.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Osanai, M. Saitoh, S. Sasaki, H. Tomita, T. Matsunaga, and K. Okumura
Effect of Shear Stress on Asymmetric Dimethylarginine Release From Vascular Endothelial Cells
Hypertension, November 1, 2003; 42(5): 985 - 990.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. H Boger
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
Cardiovasc Res, October 1, 2003; 59(4): 824 - 833.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. T. Kielstein, S. M. Bode-Boger, J. C. Frolich, E. Ritz, H. Haller, and D. Fliser
Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects
Circulation, April 15, 2003; 107(14): 1891 - 1895.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Ueda, S. Kato, H. Matsuoka, M. Kimoto, S. Okuda, M. Morimatsu, and T. Imaizumi
Regulation of Cytokine-Induced Nitric Oxide Synthesis by Asymmetric Dimethylarginine: Role of Dimethylarginine Dimethylaminohydrolase
Circ. Res., February 7, 2003; 92(2): 226 - 233.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Sydow, E. Schwedhelm, N. Arakawa, S. M. Bode-Boger, D. Tsikas, B. Hornig, J. C. Frolich, and R. H. Boger
ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins
Cardiovasc Res, January 1, 2003; 57(1): 244 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Hermenegildo, P. Medina, M. Peiro, G. Segarra, J. M. Vila, J. Ortega, and S. Lluch
Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Hyperthyroid Patients
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5636 - 5640.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom
Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease
Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger
The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function
Vascular Medicine, August 1, 2002; 7(3): 213 - 225.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
R. A. Mangiafico, L. S. Malatino, T. Attina, R. Messina, and C. E. Fiore
Exaggerated Endothelin Release in Response to Acute Mental Stress in Patients with Intermittent Claudication
Angiology, July 1, 2002; 53(4): 383 - 390.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Masuda, T. Tsujii, T. Okuno, K. Kihara, M. Goto, and H. Azuma
Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1730 - R1738.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. C. Stuhlinger, F. Abbasi, J. W. Chu, C. Lamendola, T. L. McLaughlin, J. P. Cooke, G. M. Reaven, and P. S. Tsao
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
JAMA, March 20, 2002; 287(11): 1420 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A. Silvestro, G. Oliva, and G. Brevetti
Intermittent claudication and endothelial dysfunction
Eur. Heart J. Suppl., March 1, 2002; 4(suppl_B): B35 - B40.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
P. Perrone-Filardi and M. Chiariello
Coronary artery disease and intermittent claudication: how to manage the patient
Eur. Heart J. Suppl., March 1, 2002; 4(suppl_B): B58 - B62.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Cannon III
Oral L-arginine (and other active ingredients) for ischemic heart disease?
J. Am. Coll. Cardiol., January 2, 2002; 39(1): 46 - 48.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. T. Kielstein, R. H. Boger, S. M. Bode-Boger, J. C. Frolich, H. Haller, E. Ritz, and D. Fliser
Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease
J. Am. Soc. Nephrol., January 1, 2002; 13(1): 170 - 176.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. M. Matata and M. Galinanes
Effect of Diabetes on Nitric Oxide Metabolism During Cardiac Surgery
Diabetes, November 1, 2001; 50(11): 2603 - 2610.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. T. Kielstein, J. C. Frolich, H. Haller, and D. Fliser
ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?
Nephrol. Dial. Transplant., September 1, 2001; 16(9): 1742 - 1745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Lundman, M. J. Eriksson, M. Stuhlinger, J. P. Cooke, A. Hamsten, and P. Tornvall
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 111 - 116.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. G. Lamping and F. M. Faraci
Role of Sex Differences and Effects of Endothelial NO Synthase Deficiency in Responses of Carotid Arteries to Serotonin
Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 523 - 528.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Gielen, G. Schuler, and R. Hambrecht
Exercise Training in Coronary Artery Disease and Coronary Vasomotion
Circulation, January 2, 2001; 103 (1): e1 - e6.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Boger, S. M. Bode-Boger, P. S. Tsao, P. S. Lin, J. R. Chan, and J. P. Cooke
An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2287 - 2295.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
P R J Ames, C Tommasino, J Alves, J D Morrow, L Iannaccone, G Fossati, S Caruso, F Caccavo, and V Brancaccio
Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study
Lupus, November 1, 2000; 9(9): 688 - 695.
[Abstract] [PDF]


Home page
J. Nutr.Home page
G. Wu and C. J. Meininger
Arginine Nutrition and Cardiovascular Function
J. Nutr., November 1, 2000; 130(11): 2626 - 2629.
[Abstract] [Full Text] [PDF]


Home page